Parallax Volatility Advisers, L.P. Kiniksa Pharmaceuticals, Ltd. Put Options Transaction History

Parallax Volatility Advisers, L.P.

  • $53.5 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$13.62 - $20.2 $476,700 - $707,000
-35,000 Reduced 53.85%
30,000 $521,000
Q2 2023

Aug 14, 2023
BUY
$10.44 - $16.48 $313,200 - $494,400
30,000 Added 85.71%
65,000 $915,000
Q1 2023

May 15, 2023
BUY
$10.7 - $15.79 $374,500 - $552,650
35,000 New
35,000 $376,000
Q3 2021

Nov 15, 2021
SELL
$11.39 - $16.23 $257,414 - $366,798
-22,600 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$16.68 - $23.97 $376,968 - $541,722
22,600 New
22,600 $418,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $698M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email